2022 Clinical Pharmacology Process Chemistry 
Metabolite Tales Blog
JULY 5, 2023
Synthetic macrocycles in oncology Pactritinib is a multi-kinase JAK2/FLT3 inhibitor used for the treatment of primary and secondary myelofibrosis, approved by the FDA in 2022. Journal of Medicinal Chemistry, 66 (8), 5377-5396. Journal of Medicinal Chemistry 62 (21), 9418-9437. Ayushi Jain and Khalid Mumtaz, 2022.
Metabolite Tales Blog
JULY 5, 2023
Synthetic macrocycles in oncology Pactritinib is a multi-kinase inhibitor used for the treatment of primary and secondary myelofibrosis and was approved by the FDA in 2022. Journal of Medicinal Chemistry, 66 (8), 5377-5396. Journal of Medicinal Chemistry 62 (21), 9418-9437. Ayushi Jain and Khalid Mumtaz, 2022. Chen et al.,
Expert insights. Personalized for you.
52 
Let's personalize your content